ArticleJAMA oncology2019

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial.

Oscar Arrieta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.